Document is current
Any future updates will be listed below
-
Authors
Marturano, Francesca
Guglielmo, Priscilla
Bettinelli, Andrea https://orcid.org/0000-0002-3539-3540
Zattoni, Fabio
Novara, Giacomo
Zorz, Alessandra
Sepulcri, Matteo
Gregianin, Michele
Paiusco, Marta
Evangelista, Laura
-
Funding
Funding for this research was provided by:
Università degli Studi di Padova
- License Information
-
More Information
Article History
Received: 28 November 2022
Revised: 28 March 2023
Accepted: 30 March 2023
First Online: 20 April 2023
Declarations
:
: The scientific guarantor of this publication is Dr. Laura Evangelista.
: The authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.
: One of the authors has significant statistical expertise.
: All patients gave their informed consent for the use of their personal and clinical data.
: Patients considered in the present study are part of a prospective trial (EUDRAcT number: 2013-002511-99).
: Some study subjects have been previously reported in:Sepulcri, M.; Fusella, M.; Cuppari, L.; Zorz, A.; Paiusco, M.; Evangelista, L. Value of 18F-fluorocholine PET/CT in predicting response to radical radiotherapy in patients with localized prostate cancer. <i>Clin. Transl. Radiat. Oncol.</i> 2021, <i>30</i>, 71–77, doi:10.1016/j.ctro.2021.07.002.
: • Prospective• Observational• Performed at one institution
